BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for BIO. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: BIO is a Sell candidate.
BIO stock price ended at $0.047900 on Monday, after dropping 5.02%
On Jan 19, 2026 00:00, the price of BIO fell by 5.02%, dropping from $0.045059 to $0.047900 with 24h trading volume reaching $76.7M BIO.
BIO Technical Signals
Technical Signals Summary
Buy Signals 2
Neutral Signals 2
Sell Signals 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
BIO currently exhibits 2 buy signals and 3 sell signals. The token has been in an uptrend since 12:00 AM, with a total price change of 3.71% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for BIO
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for BIO. These insights help you make informed investment decisions.